Limited benefit of biochemical response to combination therapy with interferon and ribavirin for patients with recurrent hepatitis C after living-donor liver transplantation

被引：0
|
作者：
Ueda, Yoshihide
Takada, Yasutsugu
Haga, Hironori
Nabeshima, Motoshige
Marusawa, Hiroyuki
Ito, Takashi
Egawa, Hiroto
Tanaka, Koichi
Uemoto, Shinji
Chiba, Tsutomu
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A762 / A762
页数：1
相关论文
共 50 条
  • [41] Severe recurrent hepatitis C following liver transplantation (OLT): Treatment with combination interferon-ribavirin therapy (CT)
    Calvo, F
    Berenguer, M
    Prieto, M
    Carrasco, D
    Berenguer, J
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 187 - 187
  • [42] Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation
    Kawaoka, Tomokazu
    Takahashi, Shoichi
    Takaki, Shintaro
    Hiramatsu, Akira
    Waki, Koji
    Hiraga, Nobuhiko
    Miki, Daiki
    Tsuge, Masataka
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Onoe, Takashi
    Tashiro, Hirotaka
    Ohdan, Hideki
    Chayama, Kazuaki
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) : 1467 - 1472
  • [43] The Benefits of Interferon Treatment in Patients Without Sustained Viral Response After Living Donor Liver Transplantation for Hepatitis C
    Ikegami, T.
    Taketomi, A.
    Soejima, Y.
    Yoshizumi, T.
    Fukuhara, T.
    Kotoh, K.
    Shimoda, S.
    Kato, M.
    Maehara, Y.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4246 - 4252
  • [44] Recurrent hepatitis C after liver transplantation: On-treatment prediction of response to peginterferon/ribavirin therapy
    Hanouneh, Ibrahim A.
    Miller, Charles
    Aucejo, Federico
    Lopez, Rocio
    Quinn, Mary Kay
    Zein, Nizar N.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (01) : 53 - 58
  • [45] Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?
    Tashiro, Hirotaka
    Itamoto, Toshiyuki
    Ohdan, Hideki
    Fudaba, Yasuhiro
    Kohashi, Toshihiko
    Amano, Hironobu
    Ishiyama, Kohei
    Takahashi, Shoichi
    Aikata, Hiroshi
    Chayama, Kazuaki
    Arihiro, Koji
    Asahara, Toshimasa
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) : 959 - 960
  • [46] Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: Long-term effects on graft function and morphology
    Kornberg, A
    Hommann, M
    Tannapfel, A
    Grube, T
    Schotte, U
    Scheele, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 2259 - 2260
  • [47] The response rates in hepatitis C patients on interferon alpha and interferon+ribavirin combination therapy
    Muderrisoglu, Cuneyt
    Fincanci, Muzaffer
    Izat, Aylin
    Soysal, Ferda
    Boztas, Zeki
    Eren, Gulhan
    Polat, Hayri
    Dik, Iskender
    Sander, Ersan
    Gucin, Zuhal
    [J]. ISTANBUL MEDICAL JOURNAL, 2006, 7 (03): : 1 - 4
  • [48] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [49] Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
    Cicinnati, V. R.
    Iacob, S.
    Klein, C. G.
    Baba, H. A.
    Sotiropoulos, G. C.
    Hilgard, P.
    Erim, Y.
    Broelsch, C. E.
    Gerken, G.
    Beckebaum, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (02) : 291 - 303
  • [50] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
12345